Ketoprofen

CHEMBL571 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
254.3 g/mol
LogP
3.1
Phase
4

A nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation in conditions such as arthritis, musculoskeletal injuries, and postoperative pain. It works by inhibiting COX-1 and COX-2 enzymes that produce inflammatory prostaglandins.

Khối lượng phân tử

254,2800 g/mol

LogP

3,10

TPSA

54,40 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1

InChI

InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)

Molecular Formula

C16H14O3

HBD / HBA

1 / 3

Liên kết có thể quay

4

Nguyên tử nặng

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation in conditions such as arthritis, musculoskeletal injuries, and postoperative pain. It works by inhibiting COX-1 and COX-2 enzymes that produce inflammatory prostaglandins.

Inhibits cyclooxygenase (COX-1 and/or COX-2) enzymes, reducing the synthesis of prostaglandins and thromboxanes from arachidonic acid. This produces anti-inflammatory, analgesic, and antipyretic effects.

Yes, Ketoprofen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL571. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3825. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.